Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

This organization has no public members. You must be a member to see who’s a part of this organization.

Upon closer analysis of NVIDIA, the following trends become apparent: The stock's Price to Earnings ratio of 36.59 is lower than the industry average by 0.33x, suggesting potential value in the ...

Departments of Cardiology, Fudan University, Shanghai, China. (Y. Zou, Z.L., J.J., Q.L., J.M.J.W., K.J., X.R., Y. Zhang, C.H., Y.X., H.G., J. Lin, J.G., Y.D ...

Key suits were filed by third party mRNA and lipid pioneers that, while not having any mRNA-based products on the market themselves, leveraged their patent portfolios claiming a share of the ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other best long term growth stocks to buy according to billionaires. As per Barclays, the US ...

The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.

The partnership’s main focus is on developing the nasally delivered mRNA vaccine targeting influenza. Credit: mi_viri/Shutterstock. Ethris has partnered with contract development and manufacturing ...

Room-temperature stability aims to address significant supply chain challenges associated with some mRNA vaccines, including the dependence on ultra-low-temperature storage and complex delivery ...